[Experimental pyelonephritis, chemotherapeutic studies (review of the literature)].
D000208:Acute Disease; D000667:Ampicillin / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002701:Chloramphenicol / Q000627:therapeutic use; D002908:Chronic Disease; D003352:Corynebacterium / Q000472:pathogenicity; D004195:Disease Models, Animal; D004285:Dogs; D004927:Escherichia coli Infections / Q000150:complications; D005839:Gentamicins / Q000627:therapeutic use; D000882:Haplorhini; D007668:Kidney / Q000293:injuries; D008026:Ligation; D051379:Mice; D009268:Nalidixic Acid / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000627:therapeutic use*; D010400:Penicillin G / Q000627:therapeutic use; D011512:Proteus Infections / Q000150:complications; D011552:Pseudomonas Infections / Q000150:complications; D011704:Pyelonephritis / Q000188:drug therapy* / Q000209:etiology; D011817:Rabbits; D051381:Rats; D013203:Staphylococcal Infections / Q000150:complications; D013290:Streptococcal Infections / Q000150:complications; D013307:Streptomycin / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use*; D013752:Tetracycline / Q000627:therapeutic use; D014513:Ureter / Q000502:physiology
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D013449:Sulfonamides; D009268:Nalidixic Acid; D002701:Chloramphenicol; D000667:Ampicillin; D009582:Nitrofurantoin; D013752:Tetracycline; D010400:Penicillin G; D013307:Streptomycin
Eksperimental'nyi pielonefrit v khimioterapevticheskikh issledovaniiakh (obzor literatury.